Fundraising Fox

Diasome Pharmaceuticals

Cleveland, US · Delaware corporation · 2 known investors

BiotechHealthtech

Founders & leadership

RG
Robert GehoCo-founder
WB
W. Blair GehoCo-founder
HK
Helga KautskyExecutive

Board

MO
Michele OllierBoard director
GZ
Guiseppe ZoccoBoard director
RC
Richard CarusoBoard director
PT
Peter TollmanBoard director
FM
Frank McCaneyBoard director
TM
Thomas McDonaldBoard director
CO
Cosme OrdonezBoard director

Investors · 2

JDRF T1D FundreportedBoston
MedicxireportedLondon

Reported raises · per SEC filings

Form D private placements

$49.6M disclosed across 7 rounds · 2016–2024

▶$3.1MraisedAug 2024 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter TollmanDirector
  • Robert GehoExecutive Officer, Director
  • Frank McCaneyDirector
  • W. Blair GehoExecutive Officer, Director
  • Thomas McDonaldDirector
  • Cosme OrdonezDirector
Offering amount
$15.6M
Amount sold
$3.1M
Finders' fees
$152.1K
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedJun 2023 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas McDonaldDirector
  • Peter TollmanDirector
  • Robert GehoExecutive Officer, Director
  • Marc PennDirector
  • Frank McCaneyDirector
  • W. Blair GehoDirector
Offering amount
$15M
Amount sold
$9M
Finders' fees
$350K
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.7MraisedSep 2022 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc PennDirector
  • Robert GehoExecutive Officer, Director, Promoter
  • Thomas McDonaldDirector
  • W. Blair GehoDirector
  • Frank McCaneyDirector
Offering amount
$19.1M
Amount sold
$16.7M
Finders' fees
$537.7K
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert GehoExecutive Officer, Director, Promoter
  • Marc PennDirector
  • Frank McCaneyDirector
  • W. Blair GehoDirector
  • Thomas McDonaldDirector
Offering amount
$5M
Amount sold
$1.5M
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2020 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc PennDirector
  • Robert GehoExecutive Officer, Director, Promoter
  • W. Blair GehoDirector
  • Frank McCaneyDirector
  • Thomas McDonaldDirector
Offering amount
$2.9M
Amount sold
$2.9M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.1MraisedOct 2018 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert GehoExecutive Officer, Director
  • Thomas McDonaldDirector
  • Marc PennDirector
  • Frank McCaneyDirector
  • W. Blair GehoDirector
Offering amount
$18.6M
Amount sold
$12.1M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedJan 2017 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michele OllierDirector
  • Thomas McDonaldDirector
  • Helga KautskyExecutive Officer
  • Frank McCaneyDirector
  • Robert GehoExecutive Officer, Director
  • Guiseppe ZoccoDirector
  • W. Blair GehoDirector
  • Richard CarusoDirector
Offering amount
$8M
Amount sold
$4.3M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Diasome Pharmaceuticals could tap $100 billion market for obesity drugs - Cleveland Business Journalbizjournals.com · Feb 2024Diasome Pharmaceuticals broke through a challenging funding environment to raise $20M - Cleveland Business Journalbizjournals.com · Sep 2022Diasome Pharmaceuticals raises at least $20M for diabetes drug trials - Cleveland Business Journalbizjournals.com · Sep 2022BioCentury - Diasome raises $30M in series A roundbiocentury.com · Jul 2017Diasome Pharmaceuticals Raises $30M in Funding - FinSMEsfinsmes.com · Jul 2017Full article: An Industry update: the Latest News in Therapeutic Deliverytandfonline.com

Frequently asked questions

Who founded Diasome Pharmaceuticals?
Diasome Pharmaceuticals was founded by Robert Geho, W. Blair Geho.
Who are Diasome Pharmaceuticals's investors?
Diasome Pharmaceuticals's investors include JDRF T1D Fund, Medicxi.
How much funding has Diasome Pharmaceuticals raised?
Diasome Pharmaceuticals has disclosed $49.6M raised across 7 rounds.
Where is Diasome Pharmaceuticals headquartered?
Diasome Pharmaceuticals is headquartered in Cleveland, US.